(R)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)-3-(1H-imidazol-2-yl)benzamide

ID: ALA1078576

PubChem CID: 46882030

Max Phase: Preclinical

Molecular Formula: C25H25N5O2

Molecular Weight: 427.51

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1

Standard InChI:  InChI=1S/C25H25N5O2/c31-23(21-5-2-11-26-16-21)17-27-12-10-18-6-8-22(9-7-18)30-25(32)20-4-1-3-19(15-20)24-28-13-14-29-24/h1-9,11,13-16,23,27,31H,10,12,17H2,(H,28,29)(H,30,32)/t23-/m0/s1

Standard InChI Key:  LMXFTCYGVHDWNT-QHCPKHFHSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -3.7389   -7.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7401   -8.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0253   -8.4735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3088   -8.0602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3117   -7.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0271   -6.8205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5988   -6.8145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8828   -7.2243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6019   -5.9895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1698   -6.8091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5462   -7.2189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2591   -6.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9751   -7.2135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9753   -8.0386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6905   -8.4483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4044   -8.0331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3986   -7.2038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6829   -6.7978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1210   -8.4419    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8333   -8.0258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8291   -7.2008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5499   -8.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5514   -9.2594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2671   -9.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9805   -9.2520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9736   -8.4228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2573   -8.0177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2710  -10.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6069  -10.9824    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8654  -11.7659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6905  -11.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9417  -10.9763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  2  0
  7  8  1  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  7  9  1  1
 16 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  2  3  1  0
 20 22  1  0
 10 11  1  0
 22 23  2  0
  5  6  2  0
 23 24  1  0
 11 12  1  0
 24 25  2  0
  6  1  1  0
 25 26  1  0
 12 13  1  0
 26 27  2  0
 27 22  1  0
  1  2  2  0
 24 28  1  0
 28 29  2  0
 13 14  2  0
  5  7  1  0
 14 15  1  0
  3  4  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 28  1  0
M  END

Associated Targets(Human)

ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.51Molecular Weight (Monoisotopic): 427.2008AlogP: 3.59#Rotatable Bonds: 9
Polar Surface Area: 102.93Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.60CX Basic pKa: 9.45CX LogP: 2.69CX LogD: 0.64
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -1.29

References

1. Goble SD, Wang L, Howell KL, Bansal A, Berger R, Brockunier L, DiSalvo J, Feighner S, Harper B, He J, Hurley A, Hreniuk D, Parmee E, Robbins M, Salituro G, Sanfiz A, Streckfuss E, Watkins E, Weber AE, Struthers M, Edmondson SD..  (2010)  Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles.,  20  (6): [PMID:20181479] [10.1016/j.bmcl.2010.01.130]

Source